Alternatives to propafenone
FDA shortage status is active for propafenone; 1 same-class SPL records are listed below for registry comparison only.
Brand: Rythmol
propafenone class peers while FDA lists an active shortage
propafenone (Rythmol) is on an FDA shortage listing while 1 other Class IC Antiarrhythmic SPL records remain in this registry peer set (class inventory 2). Labeled indication field for propafenone: This medicine is used to help keep your heart rhythm normal if you have atrial fibrillation or supraventricular tachycardia.
Top FAERS reaction fields for propafenone total 2,306 reports across 10 reactions, set beside flecainide. Counts are exposure-weighted submissions, not per-patient risk.
About propafenone
Propafenone (Rythmol) is a medicine that helps control irregular heartbeats. It works by slowing down electrical signals in the heart.
Used for: This medicine is used to help keep your heart rhythm normal if you have atrial fibrillation or supraventricular tachycardia. These are types of fast or irregular heartbeats that can cause problems. It can also treat life-threatening ventricular arrhythmias. Propafenone is for people without structural heart disease.
1 Class IC Antiarrhythmic peers (wide set)
propafenone vs flecainide · FAERS reaction fields
FAERS top-reaction field "Atrial Fibrillation" shows the widest count spread between propafenone and flecainide in this extract (347-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | propafenone | flecainide |
|---|---|---|
| Atrial Fibrillation | 347 | - |
| Drug Interaction | 320 | - |
| Dizziness | 262 | - |
| Toxicity To Various Agents | 231 | - |
| Dyspnoea | 226 | - |
| Nausea | 206 | - |
| Fatigue | 201 | - |
| Asthenia | 181 | - |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
propafenone shortage vs Class IC Antiarrhythmic peer index
Shortage status
FDA shortage listing is active for propafenone (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.
Frequently Asked Questions
Does FDA list a shortage for propafenone while peers remain indexed? ▼
Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for propafenone: see also the generic vs brand label guide when reading Rythmol SPL strings.
Read our methodology - how this data is sourced, computed, and verified.